BLOG | NEWS

Fertility changes: how do you know what helped?

05 Nov 2026

By ProFertility

Two adults smiling while looking at a laptop together at a table

A better test result or a completed three-month routine can be useful progress, but it does not prove which change helped or guarantee a pregnancy. To judge a fertility plan fairly, separate what you did, what changed and the outcome you hoped to influence.

That distinction matters when you have invested time, money and hope. You may have changed a routine, attended appointments, treated an identified issue or added a supplement. At the review, “keep going” can feel too vague, while “it worked” may claim more than the evidence shows.

Our new guide to reviewing your fertility plan turns that uncertainty into a practical process. The point of a review is a better decision, not a grade for how perfectly you followed the plan.

First decide what success was meant to look like

There are several legitimate reasons to make a fertility-related change. One person wants a symptom assessed. Another is preparing for sperm freezing. Someone else needs to coordinate an identified health issue with IVF. Pregnancy may be the long-term aim, but it is not the only meaningful result of every individual action.

Imagine that an appointment resolves whether a medicine needs specialist review before preservation. That can be valuable progress even though no sample has yet been stored. Conversely, a reassuring blood result cannot establish that every part of conception is working. The starting aim determines what the review can honestly conclude.

A useful review therefore begins with a sentence: this action was intended to help with this specific issue. If nobody can complete that sentence, the first task is to clarify the purpose rather than buy another intervention.

A change after something is not automatically a change because of it

Suppose a sperm report improves after someone changes smoking habits, sleep and supplements. It is tempting to give the newest bottle all the credit. But there was no controlled comparison, several things changed and the samples may have differed in collection or timing. The report cannot separate those explanations.

This does not make the improvement meaningless. It means the explanation needs to stay proportionate. You can recognise a useful finding, continue appropriate health actions and still say that the contribution of each change is uncertain. The same reasoning protects people from blame when a result does not improve.

Our repeat semen-analysis guide explains what belongs beside two reports. The wider lesson applies beyond sperm: measurement context matters before a before-and-after story becomes a claim.

What a trial can tell us that a personal timeline cannot

The SUMMER randomised trial, published in 2025, tested one antioxidant formulation alongside standard fertility care in the Netherlands. Among participants with the main outcome available, ongoing pregnancy within six months occurred in 193 of 571 in the supplement group and 208 of 555 receiving placebo. The adjusted odds ratio was 0.85, with a 95% confidence interval of 0.66–1.09: no statistically significant benefit.

These are study-group results, not personal probabilities. The endpoint was ongoing pregnancy, not live birth, and the result does not evaluate every supplement or treatment of a diagnosed deficiency. The study is useful here because it tests a claim with a comparison group, rather than assuming a change in someone's timeline proves effectiveness.

It also shows why “we measured something” is not enough. When a claim concerns having a baby, ask whether the evidence actually studied a relevant reproductive outcome, rather than only a laboratory marker or a plausible mechanism.

Three months is not a universal fertility deadline

NICE's semen-testing guidance suggests confirmation of an abnormal result ideally around three months later, with earlier repeat testing for no sperm or a severe deficiency. That is an investigation recommendation, not a promise that three months of any particular routine will repair sperm production.

Other decisions have different clocks. A medicine concern may need review now. A repeat hormone sample may need particular timing. A preservation referral or treatment schedule should not wait for the end of an arbitrary optimisation period. Keep those decisions with the relevant clinician.

You can also seek advice before trying for a baby or before a year has passed. Proactive learning and appropriate assessment are valid choices. A long tracking record is not an entry requirement for having your concerns taken seriously.

A review should make something clearer

The next step may be to continue an appropriate action, adapt an impractical routine, stop an optional intervention, investigate a relevant uncertainty or move to specialist treatment. None is automatically the more committed choice. Moving to IVF, when appropriate, does not mean that you failed at lifestyle changes.

NICE's shared-decision guidance supports agreeing a plan, its review and what happens next, with a record of what matters to the person. In practical terms, leave with the decision, the action owner and the next contact. If the review ends with a longer list but no explanation of what it changes, ask for that connection.

Include every relevant reproductive role. Men deserve their own assessment and follow-up. Solo and LGBTQ+ routes may involve donor, storage or consent decisions that a generic conception checklist misses. Someone planning years ahead should not have their progress judged by a pregnancy they are not currently seeking.

How ProFertility turns review into direction

Our contribution is to connect the information with a practical route: education when that is enough, purposeful testing when it answers a defined need, and relevant clinical support when a finding or decision requires it. A standalone consultation remains valid.

Where coordinated work is appropriate, the six-month ProFertility Plan brings assessment, targeted investigations, clinical review, a tailored programme and reviews together. That describes the support, not a demonstrated promise to achieve pregnancy, correct every barrier or prevent IVF. Treating clinicians retain responsibility for medicines and treatment decisions.

Start with Reviewing Your Fertility Plan: Progress and Next Steps. It includes two practical tables for separating the evidence from the next decision and writing a manageable follow-up record.